Young males suffered heart inflammation at higher rates following a booster dose of Pfizer’s COVID-19 vaccine, according to newly released data from the Centers for Disease Control and Prevention (CDC).
Males aged 16 or 17 had about 139 cases of myocarditis, a form of heart inflammation, per million second doses administered, according to the data, which was drawn from the Vaccine Safety Datalink (VSD), a CDC monitoring system.
But that same group had 200 cases of myocarditis per million booster doses administered, according to the data, which was from between Dec. 14, 2020, and May 28, 2022. Over 2 million total Pfizer-BioNTech primary series were administered in children, and about 230,000 booster doses, in the time period studied….